| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |